Carfilzomib recalls

The FDA has published 2 recalls involving Carfilzomib since 2016. The latest was reported on 21 Aug 2019. Most were for foreign material. Infusion Options has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2016

Last 12 months0reported

Class I00% of total

Ongoing0latest 21 Aug 2019

Recalls per month, last 24 months

click a bar for that month

0Dec '24 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0 0Dec 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why carfilzomib is recalled

Foreign Material150%
Sterility150%

Companies

Infusion Options150%
Amgen150%

By year

2019150%
2016150%

All carfilzomib recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
21 Aug 2019Drug	CLASS II	Carfilzomib 65 MG In D5w Ivpb recalled by Infusion Options	Infusion Options	Sterility	NY
28 Dec 2016Drug	CLASS II	Kyprolis (carfilzomib) for injection, 30 mg per vial recalled by AmgenKyprolis	Amgen	Foreign Material	PR

Should you stop taking Carfilzomib?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.